Community rooted Family-owned and operated treatment center established in 1997 with a discretionary growth model and emphasis on personalized patient care, presenting a potential upsell opportunity for scalable, compliant program enhancements without disrupting core operations.

Medicated treatment Specializes in opioid dependence using Methadone and Subutex with both individual and group therapies, opening avenues to partner on expanded MAT services, patient retention programs, and counseling services to broaden treatment offerings.

Licensed expertise All therapists hold Master’s degrees and state licenses, signaling a strong clinical framework and potential collaboration on continuing education, telehealth integration, or staff training platforms to enhance treatment quality and compliance.

Size and growth Small team (2–10 employees) with revenue in the $1M–$10M range, indicating opportunities for scalable partnerships in billing optimization, EHR interoperability, and low-friction service add-ons tailored to smaller providers seeking efficiency gains.

Tech stack fit Current usage of WordPress, Google Workspace, and analytics tools suggests readiness for digital marketing enhancements, integrated patient engagement solutions, and data-driven outreach to improve patient acquisition and retention.